Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.2.2
Stockholders’ Equity (Tables)
 6 Months Ended
Jun. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted
Stock Units		  
    Number of
shares
subject to
warrants		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		  
Balance at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       2,160,757  
Granted    
-
      
-
      
-
      
-
       443,954  
Exercised    
-
      
-
      
-
      
-
       (155,620 )
Cancelled/Expired    
-
      
-
      
-
      
-
      
-
  
Balance at June 30, 2022     1,043,525     $ 2.57       118,388     $ 3.25       2,449,091  
Exercisable at June 30, 2022     1,043,525     $ 2.57       118,388     $ 3.25       2,045,211  

 
Schedule of company’s outstanding warrants and options
Warrants Outstanding   Warrants Exercisable  
Exercise Price Range   Number
Outstanding		     Weighted Average
Remaining
Contractual Life (in
years)		     Weighted Average
Exercise Price		     Number
Exercisable		     Weighted Average
Exercise Price		     Intrinsic Value  
$1.79 - $20.90     1,043,525       2.49     $ 2.57       1,043,525     $ 2.57      
           -
  

 

Options Outstanding   Options Exercisable  
Exercise Price Range   Number
Outstanding		     Weighted Average
Remaining
Contractual Life (in
years)		     Weighted Average
Exercise Price		     Number
Exercisable		     Weighted Average
Exercise Price		     Intrinsic Value  
$2.64 - $28.50     118,388       2.19     $    3.25       118,388     $ 3.25      
           -
  

 
Schedule of stock-based compensation expense
    For the three months ended     For the six months ended  
    June 30,     June 30,  
    2022     2021     2022     2021  
Stock-based compensation expense   $ 297,981     $ 729,644     $ 645,549     $ 1,230,362  

 
Schedule of stock-based compensation expense categorized by the equity components
    For the three months ended     For the six months ended  
    June 30,     June 30,  
    2022     2021     2022     2021  
Common stock   $ 297,981     $ 729,644     $ 645,549     $ 1,230,362  
Total   $ 297,981     $ 729,644     $ 645,549     $ 1,230,362